Century Therapeutics grants 74,000 options to director
Century Therapeutics director Kimberly Blackwell received a stock option grant for 74,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Century Therapeutics director Kimberly Blackwell received a stock option grant for 74,000 shares of common stock. The option has an exercise price of $2.24 per share and expires on June 11, 2036. All 74,000 options vest on the earlier of June 11, 2027 or the next annual stockholder meeting, subject to her continued service.
Insider Trade Summary
Grant/Award: 74,000 shares
Grant/Award
1 txn
Insider
Blackwell Kimberly
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 74,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 74,000 contracts (Direct)
Footnotes (1)
- F1. The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Options granted: 74,000 options
Exercise price: $2.24 per share
Options after grant: 74,000 options
+2 more
5 metrics
Options granted
74,000 options
Stock Option (right to buy) award to director
Exercise price
$2.24 per share
Stock option strike price for common stock
Options after grant
74,000 options
Total derivative holdings from this award following transaction
Expiration date
June 11, 2036
Option expiration for granted stock options
Vesting date trigger
June 11, 2027 or next annual meeting
Earlier date governs vesting, subject to continued service
Key Terms
Stock Option (right to buy, exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (right to buy financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "2.2400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Century Therapeutics (IPSC) disclose about Kimberly Blackwell in this Form 4?
Century Therapeutics reported that director Kimberly Blackwell received a grant of 74,000 stock options. These options relate to the company’s common stock and were awarded as a compensation-related acquisition rather than an open-market purchase or sale of shares.
How many Century Therapeutics (IPSC) stock options were granted to Kimberly Blackwell?
Kimberly Blackwell was granted 74,000 stock options linked to Century Therapeutics common stock. Following this grant, her reported derivative holdings from this award total 74,000 options, reflecting a new equity-based compensation award rather than a market transaction in existing shares.
What is the exercise price of Kimberly Blackwell’s Century Therapeutics (IPSC) options?
The granted stock options have an exercise price of $2.24 per share. This is the price at which she can buy Century Therapeutics common stock in the future, if the options vest and are exercised before their stated expiration date in 2036.
When do Kimberly Blackwell’s Century Therapeutics (IPSC) options vest?
The options vest on the earlier of June 11, 2027 or the next annual meeting of stockholders. Vesting is conditioned on her continued service with the company through the applicable vesting date, as described in the footnote to the filing.
What is the expiration date of Kimberly Blackwell’s Century Therapeutics (IPSC) stock options?
The granted stock options are scheduled to expire on June 11, 2036. If they are not exercised by that expiration date, they will lapse. This long duration is typical of director and executive option awards with multi-year vesting schedules.
Is Kimberly Blackwell’s Century Therapeutics (IPSC) Form 4 a stock purchase or a compensation grant?
The Form 4 reflects a compensation grant, not an open-market purchase. The transaction code is “A”, described as a grant, award, or other acquisition of a derivative security (stock option) with an exercise price of $2.24 and future vesting conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
